Bayesian estimates of the prevalence of β-thalassemia trait in voluntary blood donors of central India: A survey

Hemoglobin

Volumn 34, Issue 6, 2010, Pages 548-560

  Chatterjee, Nirupama ^a   Mishra, Amit ^a   Soni, Ravindra ^a   Kulkarni, Hemant ^b,c,d   Mamtani, Manju ^b,c,d   Shrivasatava, Manisha ^a  

^a BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

^b Lata Medical Research Foundation   (India)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Thalassemia ( thal) trait; Bayesian methods; India; Madhya Pradesh; Voluntary blood donors

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A2;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD DONOR; BLOOD EXAMINATION; CLINICAL PROTOCOL; FEMALE; GENE FLOW; GENETIC TRAIT; GROUPS BY AGE; HEALTH PROGRAM; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; MALE; NAKED EYE SINGLE TUBE RED CELL OSMOTIC FRAGILITY TEST; POPULATION; PREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BAYES THEOREM; BETA-THALASSEMIA; BLOOD DONORS; CROSS-SECTIONAL STUDIES; FEMALE; GEOGRAPHY; HEALTH SURVEYS; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; SEX FACTORS; YOUNG ADULT;

EID: 79952144553     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2010.526488     Document Type: Article

References (44)

1. Delea TE, Edelsberg J, Sofrygin O, et al. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion. 2007;47(10):1919-1929. (Pubitemid 47438560)
2. Delea TE, Sofrygin O, Thomas SK, Baladi JF, Phatak PD, Coates TD. Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective. Pharmacoeconomics. 2007;25(4):329-342. (Pubitemid 46607383)
3. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med. 2007;17(6):425-433. (Pubitemid 350198296)
4. Scriver CR. Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine. Community Genet. 2006;9(3):142-152. (Pubitemid 43854178)
5. Shah A. Thalassemia syndromes. Indian J Med Sci. 2004;58(10):445-449.
6. Gulbis B, Cotton F, Ferster A, et al. Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol. 2009;62(1):49-52.
7. Gulbis B, Tshilolo L, Cotton F, Lin C, Vertongen F. Newborn screening for haemoglobinopathies: the Brussels experience. J Med Screen. 1999;6(1):11-15. (Pubitemid 29164738)
8. Kabra M. Prenatal diagnosis. Indian J Pediatr. 2003;70(1):81-85. (Pubitemid 36249590)
9. Maheshwari M, Arora S, Kabra M, Menon PS. Carrier screening and prenatal diagnosis of β-thalassemia. Indian Pediatr. 1999;36(11):1119-1125.
10. Sur D, Mukhopadhyay SP. Prevalence of thalassaemia trait in the state of West Bengal. J Indian Med Assoc. 2006;104(1):11-15. (Pubitemid 44032773)
11. Mulchandani DV, Fulare MB, Zodpey SP, Vasudeo ND. Prevalence and some epidemiological factors of β thalassaemia trait in Sindhi community of Nagpur City, India. Indian J Public Health. 2008;52(1):11-15.
12. Jawahirani A, Mamtani M, Das K, Rughwani V, Kulkarni H. Prevalence of β-thalassaemia in subcastes of Indian Sindhis: results from a two-phase survey. Public Health. 2007;121(3):193-198. (Pubitemid 46223911)
13. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med. 2002;347(15):1162-1168.
14. Gorakshakar AC, Colah RB. Cascade screening for β-thalassemia: a practical approach for identifying and counseling carriers in India. Indian J Community Med. 2009;34(4):354-356.
15. Alkindi S, Al Zadjali S, Al Madhani A, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010;34(2):135-144.
16. Brandelise S, Pinheiro V, Gabetta CS, Hambleton I, Serjeant B, Serjeant G. Newborn screening for sickle cell disease in Brazil: the Campinas experience. Clin Lab Haematol. 2004;26(1):15-19. (Pubitemid 38241475)
17. Lobel JS, Cameron BF, Johnson E, Smith D, Kalinyak K. Value of screening umbilical cord blood for hemoglobinopathy. Pediatrics. 1989;83(5, Pt. 2):82382-6.
18. Benjamin AI, Singh S, Sengupta P, Dhanoa J. HIV sero-prevalence and knowledge, behaviour and practices regarding HIV/AIDS in specific population groups in Ludhiana, Punjab. Indian J Public Health. 2007;51(1):33-38.
19. Tondon R, Pandey P, Chaudhary R. Vasovagal reactions in 'at risk' donors: a univariate analysis of effect of age and weight on the grade of donor reactions. Transfus Apher Sci. 2008;39(2):95-99.
20. Mangla B. India: HIV-positive blood donors. Lancet. 1993;341(8859):1527- 1528. (Pubitemid 23168660)
21. Miller D, Kalibala S, Anderson S, Emmanuel J, Petitgirard A. Blood donor counseling for HIV: results of a multi-country feasibility study. Public Health. 1994;108(3):219-226.
22. Casado A, Casado MC, Lopez-Fernandez ME, Venarucci D. Thalassemia and G6PD deficiency in Spanish blood donors. Panminerva Med. 1997;39(3):205-207. (Pubitemid 127520550)
23. Lisot CL, Silla LM. [Screening for hemoglobinopathies in blood donors from Caxias do Sul, Rio Grande do Sul, Brazil: prevalence in an Italian colony]. Cad Saude Publica. 2004;20(6):1595-1601.
24. Niazi GA, Fleming AF. Haematological status of blood-donors with sickle cell trait and α thalassaemia in northern Nigeria. East Afr Med J. 1989;66(12):824-829.
25. Rosline H, Ahmed SA, Al-Joudi FS, Rapiaah M, Naing NN, Adam NA. Thalassemia among blood donors at the Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health. 2006;37(3):549-552.
26. Mehta BC. NESTROFT: a screening test for β thalassemia trait. Indian J Med Sci. 2002;56(11):537-545.
27. Rao S, Saxena R, Deka D, Kabra M. Use of Hb A estimation by CE-HPLC for prenatal diagnosis of β-thalassemia; experience from a tertiary care centre in north India: a brief report. Hematology. 2009;14(2):122-124.
28. Enoe C, Georgiadis MP, Johnson WO. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown. Prev Vet Med. 2000;45(1-2):61-81. (Pubitemid 30308340)
29. Walter SD, Irwig LM. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. J Clin Epidemiol. 1988;41(9):923-937.
30. Mamtani M, Jawahirani A, Das K, Rughwani V, Kulkarni H. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for β-thalassemia. Hematology. 2006;11(4):277-286. (Pubitemid 44963706)
31. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. (Pubitemid 34746062)
32. Chattopadhyay S. 'Rakter dosh'-corrupting blood: the challenges of preventing thalassemia in Bengal, India. Soc Sci Med. 2006;63(10):2661-2673.
33. Colah R, Surve R, Wadia M, et al. Carrier screening for β-thalassemia during pregnancy in India: a 7-year evaluation. Genet Test. 2008;12(2):181-185. (Pubitemid 351860433)
34. Tamhankar PM, Agarwal S, Arya V, Kumar R, Gupta UR, Agarwal SS. Prevention of homozygous β thalassemia by premarital screening and prenatal diagnosis in India. Prenat Diagn. 2009;29(1):83-88.
35. Delanghe J, Langlois M, Alvarado Esquivel C, De Haene H, De Buyzere M. Haptoglobin 1F allele frequency is high among indigenous populations in the state of Durango, Mexico. Hum Hered. 2000;50(4):263-265.
36. Keller SR, Sowell DR, Neiman M, Wolfe LM, Taylor DR. Adaptation and colonization history affect the evolution of clines in two introduced species. New Phytol. 2009;183(3):678-690.
37. Laurent V, Voisin M, Planes S. Genetic clines in the Bay of Biscay provide estimates of migration for Sardina pilchardus. J Hered. 2006;97(1): 81-88. (Pubitemid 43214177)
38. Lucotte G, Gerard N, Mercier G. North African genes in Iberia studied by Y-chromosome DNA haplotype 5. Hum Biol. 2001;73(5):763-769. (Pubitemid 33145721)
39. Petry D. The effect on neutral gene flow of selection at a linked locus. Theor Popul Biol. 1983;23(3):300-313.
40. Rao VR, Sathe MS, Gorakshakar AC, Vasantha K. Genetic heterogeneity and population structure of Gond-related tribes in the Vidarbha region of Maharashtra. Hum Biol. 1992;64(6):903-917.
41. Das SK, Talukder G. A review on the origin and spread of deleterious mutants of the beta-globin gene in Indian populations. Homo. 2001;52(2):93-109. (Pubitemid 33587783)
42. Colah R, Gorakshakar A, Phanasgaonkar S, et al. pidemiology of α-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat. Br J Haematol. 2010;149(5):739-747.
43. Gorakshakar AC, Das MK, Phanasgaokar SP, Nadkarni AH, Colah RB, Mohanty D. Origin of the codon 47 (+A) β-thalassaemia mutation among the Nicobarese of the Andaman and Nicobar islands in India. Br J Haematol. 2007;139(2):345-346. (Pubitemid 47493094)
44. Tyagi S, Saxena R, Choudhry VP. HPLC-how necessary is it for haemoglobinopathy diagnosis in India? Indian J Pathol Microbiol. 2003;46(3):390-393.